Effects of modulating M3 muscarinic receptor activity on azoxymethane-induced liver injury in mice

Biochemical Pharmacology

Volumn 86, Issue 2, 2013, Pages 329-338

  Khurana, Sandeep ^a   Jadeja, Ravirajsinh ^a   Twaddell, William ^a   Cheng, Kunrong ^a   Rachakonda, Vikrant ^a   Saxena, Neeraj ^a   Raufman, Jean Pierre ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Azoxymethane; Darifenacin; Liver injury; Muscarinic receptors; Pilocarpine

Indexed keywords

3 NITROTYROSINE; ALPHA SMOOTH MUSCLE ACTIN; AZOXYMETHANE; CASPASE 3; COLLAGEN; COLLAGENASE 3; DARIFENACIN; GELATINASE A; MESSENGER RNA; MUSCARINIC M3 RECEPTOR; PILOCARPINE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; LIVER FIBROSIS; LIVER INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84884907991     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.05.010     Document Type: Article

References (45)

1. Ikeda O, Ozaki M, Murata S, Matsuo R, Nakano Y, Watanabe M, et al. Autonomic regulation of liver regeneration after partial hepatectomy in mice. J Surg Res 2009;152:218-23.
2. Ohtake M, Sakaguchi T, Yoshida K, Muto T. Hepatic branch vagotomy can suppress liver regeneration in partially hepatectomized rats. HPB Surg 1993;6:277-86. (Pubitemid 23295546)
3. Cassiman D, Libbrecht L, Sinelli N, Desmet V, Denef C, Roskams T. The vagal nerve stimulates activation of the hepatic progenitor cell compartment via muscarinic acetylcholine receptor type 3. Am J Pathol 2002;161:521-30. (Pubitemid 36142161)
4. Bernik TR, Friedman SG, Ochani M, DiRaimo R, Susarla S, Czura CJ, et al. Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg 2002;36:1231-6. (Pubitemid 36236348)
5. Hiramoto T, Chida Y, Sonoda J, Yoshihara K, Sudo N, Kubo C. The hepatic vagus nerve attenuates Fas-induced apoptosis in the mouse liver via alpha7 nicotinic acetylcholine receptor. Gastroenterology 2008;134:2122-31. (Pubitemid 351783265)
6. Shah N, Khurana S, Cheng K, Raufman JP. Muscarinic receptors and ligands in cancer. Am J Physiol Cell Physiol 2009;296:C221-32.
7. Wess J, Eglen RM, Gautam D. Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov 2007;6: 721-33. (Pubitemid 47342315)
8. Li JH, Gautam D, Han SJ, Guettier JM, Cui Y, Lu H, et al. Hepatic muscarinic acetylcholine receptors are not critically involved in maintaining glucose homeostasis in mice. Diabetes 2009;58:2776-87.
9. Laqueur GL, Mickelsen O, Whiting MG, Kurland LT. Carcinogenic properties of nuts from Cycas circinalis L. indigenous to Guam. J Natl Cancer Inst 1963;31:919-51.
10. Fiala ES. The formation of azoxymethane, a colon carcinogen, during the chemical oxidation of methylamine. Carcinogenesis 1980;1:57-60. (Pubitemid 11185308)
11. Belanger M, Cote J, Butterworth RF. Neurobiological characterization of an azoxymethane mouse model of acute liver failure. Neurochem Int 2006;48:434-40.
12. Matkowskyj KA, Marrero JA, Carroll RE, Danilkovich AV, Green RM, Benya RV. Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model. Am J Physiol 1999;277:G455-62. (Pubitemid 29415073)
13. Ward JM. Hepatic lesions caused by azoxymethane-a synthetic analogue of a natural plant product. Vet Pathol 1975;12:64.
14. Shan W, Nicol CJ, Ito S, Bility MT, Kennett MJ, Ward JM, et al. Peroxisome proliferator-activated receptor-beta/delta protects against chemically induced liver toxicity in mice. Hepatology 2008;47:225-35. (Pubitemid 351171060)
15. Wargovich MJ, Satterfield W, Price RE, Stephens LC, Coghlan L. Hepatic pathology of the colon carcinogen, azoxymethane, in Hanford-Moore miniature pigs. J Comp Pathol 1991;105:271-8.
16. Iredale J. Defining therapeutic targets for liver fibrosis: exploiting the biology of inflammation and repair. Pharmacol Res 2008;58:129-36.
17. Khurana S, Shah N, Cheng K, Shiu B, Samimi R, Belo A, et al. Scopolamine treatment and muscarinic receptor subtype-3 gene ablation augment azoxymethane-induced murine liver injury. J Pharmacol Exp Ther 2010;333: 639-49.
18. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
19. Cheng K, Raufman JP. Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors. Biochem Pharmacol 2005;70:1035-47. (Pubitemid 41262079)
20. Shant J, Cheng K, Marasa BS, Wang JY, Raufman JP. Akt-dependent NF-kappaB activation is required for bile acids to rescue colon cancer cells from stressinduced apoptosis. Exp Cell Res 2009;315:432-50.
21. Fallowfield JA. Therapeutic targets in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2011;300:G709-15.
22. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006;43: S45-53.
23. Canbay A, Friedman S, Gores GJ. Apoptosis: the nexus of liver injury and fibrosis. Hepatology 2004;39:273-8. (Pubitemid 38222163)
24. Kikuchi H, Katsuramaki T, Kukita K, Taketani S, Meguro M, Nagayama M, et al. New strategy for the antifibrotic therapy with oral administration of FR260330 (a selective inducible nitric oxide synthase inhibitor) in rat experimental liver cirrhosis. Wound Repair Regen 2007;15:881-8. (Pubitemid 350135239)
25. Dogru-Abbasoglu S, Parildar-Karpuzoglu H, Balkan J, Aykac-Toker G, Uysal M. Nitrotyrosine formation and heme oxygenase-1 expression in endotoxemic cirrhotic rats. Arch Med Res 2007;38:28-33. (Pubitemid 44894611)
26. Wu CT, Eiserich JP, Ansari AA, Coppel RL, Balasubramanian S, Bowlus CL, et al. Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions. Hepatology 2003;38:1018-25. (Pubitemid 37221685)
27. Sanz-Cameno P, Medina J, Garcia-Buey L, Garcia-Sanchez A, Borque MJ, Martin-Vilchez S, et al. Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol 2002;37:723-9. (Pubitemid 35404209)
28. Nelson CP, Gupta P, Napier CM, Nahorski SR, Challiss RA. Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland. J Pharmacol Exp Ther 2004;310:1255-65. (Pubitemid 39108948)
29. Sykes DA, Dowling MR, Charlton SJ. Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor. Mol Pharmacol 2009;76:543-51.
30. Figueroa KW, Griffin MT, Ehlert FJ. Selectivity of agonists for the active state of M1 to M4 muscarinic receptor subtypes. J Pharmacol Exp Ther 2009;328: 331-42.
31. Bockx I, Verdrengh K, Vander Elst I, van Pelt J, Nevens F, Laleman W, et al. Highfrequency vagus nerve stimulation improves portal hypertension in cirrhotic rats. Gut 2012;61:604-12.
32. Bruck R, Shirin H, Aeed H, Matas Z, Hochman A, Pines M, et al. Prevention of hepatic cirrhosis in rats by hydroxyl radical scavengers. J Hepatol 2001;35:457-64. (Pubitemid 32964444)
33. Bruck R, Aeed H, Shirin H, Matas Z, Zaidel L, Avni Y, et al. The hydroxyl radical scavengers dimethylsulfoxide and dimethylthiourea protect rats against thioacetamide-induced fulminant hepatic failure. J Hepatol 1999;31:27-38. (Pubitemid 29287606)
34. Jaeschke H, Cover C, Bajt ML. Role of caspases in acetaminophen-induced liver injury. Life Sci 2006;78:1670-6. (Pubitemid 43276472)
35. Shirin H, Aeed H, Alin A, Matas Z, Kirchner M, Brazowski E, et al. Inhibition of immune-mediated concanavalin a-induced liver damage by free-radical scavengers. Dig Dis Sci 2010;55:268-75.
36. Essani NA, Fisher MA, Jaeschke H. Inhibition of NF-kappa B activation by dimethyl sulfoxide correlates with suppression of TNF-alpha formation, reduced ICAM-1 gene transcription, and protection against endotoxin-induced liver injury. Shock 1997;7:90-6. (Pubitemid 127654254)
37. Kelly KA, Hill MR, Youkhana K, Wanker F, Gimble JM. Dimethyl sulfoxide modulates NF-kappa B and cytokine activation in lipopolysaccharide-treated murine macrophages. Infect Immun 1994;62:3122-8. (Pubitemid 24232091)
38. Masson MJ, Carpenter LD, Graf ML, Pohl LR. Pathogenic role of natural killer T and natural killer cells in acetaminophen-induced liver injury in mice is dependent on the presence of dimethyl sulfoxide. Hepatology 2008;48:889-97.
39. Hemmann S, Graf J, Roderfeld M, Roeb E. Expression of MMPs and TIMPs in liver fibrosis-a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 2007;46:955-75. (Pubitemid 46529049)
40. Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008;134:1641-54. (Pubitemid 351615416)
41. Curia G, Longo D, Biagini G, Jones RS, Avoli M. The pilocarpine model of temporal lobe epilepsy. J Neurosci Methods 2008;172:143-57.
42. Clouston AD, Powell EE, Walsh MJ, Richardson MM, Demetris AJ, Jonsson JR. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 2005;41:809-18. (Pubitemid 40462943)
43. Richardson MM, Jonsson JR, Powell EE, Brunt EM, Neuschwander-Tetri BA, Bhathal PS, et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 2007;133:80-90. (Pubitemid 47031146)
44. Svegliati-Baroni G, Faraci G, Fabris L, Saccomanno S, Cadamuro M, Pierantonelli I, et al. Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. Gut 2011;60:108-15.
45. Chobert MN, Couchie D, Fourcot A, Zafrani ES, Laperche Y, Mavier P, et al. Liver precursor cells increase hepatic fibrosis induced by chronic carbon tetrachloride intoxication in rats. Lab Invest 2011;92:135-50.